Oligosaccharide for Cdiff(+) Heme-onc Patients

Plain-language summary

This study evaluates the use of potato starch, as a source of oligosaccharide, in hematology-oncology patients who carry C. difficile. Patients aged 18 and older with a positive C. difficile test, no diarrhea or abdominal pain in the past 48 hours, and admitted to a hematology-oncology unit were able to take part. This was a phase-not-applicable study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

Medical College of Wisconsin

Intervention

Potato starch

Start date

6/1/2019

Estimated completion

8/1/2021

Countries

United States

Related genes

Locations

• Milwaukee, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

Patients must meet all inclusion criteria to be eligible to participate in the study.

* Patients must be at least 18 years of age at time of consent.
* Positive C. difficile surveillance test.
* Absence of diarrhea or abdominal pain within the past 48 hours.
* Patient admitted in a hematology-oncology unit which for the purposes of this study will be defined as 7-CFAC and 8-CFAC.

Exclusion Criteria:

Patients must NOT meet any exclusion criteria to be eligible to participate in the study.

* Presence of \>= grade I nausea/vomiting.
* Inability to take oral medications or food.
* Expected length of hospitalization or survival less than 5 days
* Patient is only boarding in hematology-oncology units and would have not otherwise been admitted to these units.
* Unwillingness or inability to provide written informed consent.
* Women known to be pregnant or lactating during the study.
* History of inflammatory bowel disease.